• ECONOMIC Evaluation of Nt-Probnp Guided Therapy in Patients with Chronic Heart Failure

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Varicella Vaccination In Peru

    Oct 1, 2017, 00:00

  • A Comparison Of The Appraisals By The English National Institute For Health And Care Excellence (NICE) For Two Therapies For Relapsed Or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL)- Idelalisib+Rituximab (IR) And Ibrutinib

    Oct 1, 2017, 00:00

  • Technical Challenges in Cost-Effectiveness Analysis for Oncology Treatments- Identifying Frequent Issues in Modelling From Nice Perspective

    Oct 1, 2017, 00:00

  • Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population

    Oct 1, 2017, 00:00

  • Employment Relationship And Glycemic Control In Type 2 Diabetes Patients

    Oct 1, 2017, 00:00

  • Evaluation of Health Care Reform Impact on Cancer Patients` Access To Medicine- A Pilot-Center Experience in Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Factors Associated with Quality of Life(QOL) In Peripheral Arterial Disease(PAD) Patients in Korea- Results from Pad Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • Local Production Policies In The Turkish Pharmaceutical Market

    Oct 1, 2017, 00:00

  • Economic Impact Of Atopic Dermatitis In Adults- A Population Study (Idea Study)

    Oct 1, 2017, 00:00

  • Regulatory Requirements for Non-Interventional Studies Collecting Patient Preferences and Experiences In France, Germany and The UK

    Oct 1, 2017, 00:00

  • The Burden And Cost Of Illness Of Gout In Secondary Care In England

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies For Public Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Economic Evaluation of using a Combination of Helicobacter Pylori Antibody and Serum Pepsinogen Levels for Gastric Cancer-Risk Screening in Japan

    Oct 1, 2017, 00:00

  • A Real Word Treatment Patterns and Trends In Painful Diabetic Neuropathy and Postherpatic Neuralgia

    Oct 1, 2017, 00:00

  • Patients With High Comorbidity And Transitioning To Dialysis At High Risk Of Suboptimal Antihypertensive Medication Prescription Use- Results From A Brazilian National Cohort (BRAZPD) Of Peritoneal Dialysis

    Oct 1, 2017, 00:00

  • Inter-State Variability Of Adult Vaccination Coverage In The United States- Can We Explain It?

    Oct 1, 2017, 00:00

  • Multiple Myeloma- Epidemiology and Burden of Disease Analysis in Latin America

    Oct 1, 2017, 00:00

  • Use of Disease Risk Score In The Evaluation of Effectiveness For Purposes of HTA

    Oct 1, 2017, 00:00

  • Cost Benefit Analysis in The Treatment of Severe Osteoporosis from The Public Healthcare System Perspective in Mexico

    Oct 1, 2017, 00:00

  • The Use Of Matching Adjusted Indirect Comparison (MAIC) And Simulated Treatment Comparison (STC) In Hta Submissions; Learnings From Recent Submissions

    Oct 1, 2017, 00:00

  • Comparing Efficacy of Guselkumab Versus Ustekinumab in Moderate to Severe Psoriasis Patients - An Adjusted Comparison Based on Voyage 12 and Navigate Trials

    Oct 1, 2017, 00:00

  • Enhanced Surgical Recovery Program Perioperative Goal Directed Therapy (PGDT) Economic Benefit

    Oct 1, 2017, 00:00

  • Would a Two-Dose Rotavirus Vaccine Improve Health Outcomes While Reducing Costs in the Sultanate of Oman?

    Oct 1, 2017, 00:00

  • Depression Assessment in Patients Diagnosed with Parkinson’s Disease for Clinical Practice

    Oct 1, 2017, 00:00

  • Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis- Nash-Check

    Oct 1, 2017, 00:00

  • Radar – An Important Tool for Horizon Scanning Dissemination in Brazil

    Oct 1, 2017, 00:00

  • Antithrombotic Treatments in Patients with Acute Ischemic Stroke and Non-Valvular Atrial Fibrillation Before Introduction of Non-Vitamin K Antagonist Oral Anticoagulants Into Practice in Korea

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC)- Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel

    Oct 1, 2017, 00:00

  • Challenges and Future Perspectives on The Reimbursement of Advanced Therapy Medicinal Products

    Oct 1, 2017, 00:00

  • Work Accident Costs. Security, Healthcare and Human Resources Departments Links

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients with Acute Lymphoblastic Leukemia with Philadelphia Chromosome Positive (PH+ ALL), Suitable for Allogeneic Stem Cell Transplant, in Greece

    Oct 1, 2017, 00:00

  • COMPARISON OF VARIOUS SEVERITY ASSESSMENT SCORING SYSTEMS IN PATIENTS WITH SEPSIS

    Oct 1, 2017, 00:00

  • Health Insurance Cost Of Migraine In Hungary- A Cost Of Illness Study

    Oct 1, 2017, 00:00

  • Comparing Cost-Effectiveness of Strategies for Antenatal Hiv Testing- VCT and Routine Testing in Urban Nigeria

    Oct 1, 2017, 00:00

  • Healthcare Resource Use and Costs In Patients With Major Depressive Disorder Switching From A Generic To A Branded Antidepressant

    Oct 1, 2017, 00:00

  • Costs Of Ownership Of Ready-To-Administer Pre-Filled Sterilized Syringes In A Dutch Hospital; A Cost Minimization Analysis

    Oct 1, 2017, 00:00

  • Identifying Inpatients To Outpatient Parenteral Antimicrobial Therapy- A Point Prevalence Study

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Crohn’s Disease- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Patient’s Journey Through Acute Myeloid Leukemia (AML)- Understanding AML’s Humanistic Impact Through an International Patient-Centric Qualitative Study

    Oct 1, 2017, 00:00

  • Opportunity Cost Of Non-Rigorous Or Non-Transferable Research- Implications For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Validação Do Método Simple Exponential Smoothing with Additive Para Realização De Previsões De Gasto Com Importação De Produtos Farmacêuticos

    Oct 1, 2017, 00:00

  • Disinvestment of Health Technologies by the National Commission for Technology Incorporation from 2012-2016

    Oct 1, 2017, 00:00

  • Estimates of PFS, TTNT Per Treatment Line and their Relationship for Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Patient Input into Value Assessment of Respiratory Medicines- Lessons Learned from Value Frameworks in other Disease Areas

    Oct 1, 2017, 00:00

  • Evaluación De Pertinencia Científica Y Análisis De Costo-Efectividad En Las Intervenciones De Salud

    Oct 1, 2017, 00:00

  • HCV Network Of Sicilian Region- A Best Practice To Monitor Cost And Consequence Of Treatments

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Cisplatin-Induced Nephrotoxicity- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • PRM178Evaluation And Validation Of The Proact Measures For Cancer Patients And Informal Caregivers

    Oct 1, 2017, 00:00

  • Will 2017 Updates To The Highly Specialised Technologies Programme Benefit or Harm Vulnerable Patients?

    Oct 1, 2017, 00:00

  • Caregiver Burden In Daily Human Growth Hormone Injections For Children

    Oct 1, 2017, 00:00

  • The Resource And Cost Consequences Of Using Antibiotic Coated Intramedullary Nails Compared To Non-Coated Nails In Open Tibia Fractures Across Four European Centres

    Oct 1, 2017, 00:00

  • Sentiment Analysis of Social Media Posts from Renal Cell Carcinoma (RCC) Patients

    Oct 1, 2017, 00:00

  • The Impact Of Long Acting Injectable Antipsychotics On The Health And Economic Outcomes Of Schizophrenia Patients In Brazil

    Oct 1, 2017, 00:00

  • Do Changing Attitudes To Death Have Implications For National Tariffs For Health States? Results From An Examination Of Attitudes To Euthanasia In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Study To Evaluate Insulin Glargine Compared With NPH Insulin In Patients With Type 2 Diabetes Uncontrolled With Oral Anti-Diabetic Agents In Hong Kong

    Oct 1, 2017, 00:00

  • Predicting Outcomes From Multiple Uncontrolled Historical Studies of Treatment of Physician’s Choi Progression-Free Survival And Overall Survival In Untreated Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Evaluating Cost of Regimens in Hepatitis C Treatment from Healthcare Payer Vietnam’s Perspective

    Oct 1, 2017, 00:00

  • Medical Cost Evaluation of Apixaban Versus Warfarin In Patients With Nonvalvular Atrial Fibrillation- Japanese Claims Database Analysis

    Oct 1, 2017, 00:00

  • Immunobiological Use Profile In The Service of Rheumatology of A Heatlhcare Provider

    Oct 1, 2017, 00:00

  • Characteristics And Treatment Patterns In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • Evaluation Of Measles Vaccination Coverage In Austria

    Oct 1, 2017, 00:00

  • Profile of Brazilian Inpatients With Mental Disorders Covered By Private Health Care In The State of Ceara- A Real World Data Analysis

    Oct 1, 2017, 00:00

  • Cost Analysis of Lung Cancer in China

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Mexico

    Oct 1, 2017, 00:00

  • Cost Impact of Protocol Compliance for Cancer Treatment Plans in The Private Healthcare Environment

    Oct 1, 2017, 00:00

  • School Communities’ Participation In Health Promotion Process In Lithuania

    Oct 1, 2017, 00:00

  • The Role Of Disability On Early Retirement

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Randomized Trial Of An Mhealth Intervention To Improve Cardiometabolic Profile In Prehypertensive Subjects From Low-Resource Urban Settings In Latin America

    Oct 1, 2017, 00:00

  • Impact Of Lifestyle Education And Pharmacist Intervention Of Drug-Related Problems On Elders At High Risk Of Having Dementia

    Oct 1, 2017, 00:00

  • Costs Analysis Of Novel Flash Glucose Monitoring Technology In Adults With Type 2 Diabetes Mellitus (T2DM) Under Insulin Treatment In Spain

    Oct 1, 2017, 00:00

  • How Far Equity Has Been Achieved in the Indonesian Universal Health Coverage?

    Oct 1, 2017, 00:00

  • Crises Econômicas E Seus Impactos No Sistema De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Public Hospital Supply Chain- Current View And Critical Issues In Italy

    Oct 1, 2017, 00:00

  • Assessment of Lipid-Lowering Therapy Prescribing Among Patients with Type 2 Diabetes Mellitus in Malaysian Primary Care Settings

    Oct 1, 2017, 00:00

  • Comparative Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) And Warfarin In The Scottish Atrial Fibrillation Population- The Value of Real World Evidence

    Oct 1, 2017, 00:00

  • Patterns of Biologics Use In Ankylosing Spondylitis And Psoriatic Arthritis Patients In Korea

    Oct 1, 2017, 00:00

  • What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework

    Oct 1, 2017, 00:00

  • Case Fatality Rate of Enteric Fever- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Analysis of Using Irp as A Launch Price Setting Mechanism

    Oct 1, 2017, 00:00

  • A Qualitative Exploration of Reasons for (NON-) Adherence to Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Waiting List Mortality Impact in Hcv Cirrhotic Patients

    Oct 1, 2017, 00:00

  • Economic Impact Of Nurse Sensitive Outcomes In Irish Hospitals

    Oct 1, 2017, 00:00

  • Screening For Asymptomatic Atrial Fibrillation- Its Effectiveness And Cost-Effectiveness Of Repeated Ecg In Poland

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 15mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Relación Entre Los Factores Sociodemográfico, Económicos, Condición Clínica Y La Calidad De Vida Relacionada A Salud- Explorando La Eq-5d Y Eq-Vas En Chile

    Oct 1, 2017, 00:00

  • Understanding Hta and Patient Engagement- Effect of Integrating Experiential and Knowledge Learning Modules

    Oct 1, 2017, 00:00

  • Avaliação Da Indicação Terapêutica Da Metilprednisolona No Tratamento Adjunto De Pessoas Portadoras De Pneumonia Por Pneumocystis Carinii

    Oct 1, 2017, 00:00

  • Análise De Custo-Comparação Entre Os Programas Para Pessoas Com Deficiência Intelectual E Do Desenvolvimento Cognitivo- Suporte Individualizado E Instituições De Saúde Mental

    Oct 1, 2017, 00:00

  • Dosing Patterns Associated With Deflazacort Use In Duchenne Muscular Dystrophy (DMD)- Observations From Deflazacort Early Access Program (EAP) In The U.S

    Oct 1, 2017, 00:00

  • Flaring Among Atopic Dermatitis Patients – The Perception of Flaring Burden Between Physicians and Patients

    Oct 1, 2017, 00:00

  • Estratégias Intitucionais Como Mecanismo De Racionalização Das Demandas Judiciais De Medicamentos

    Oct 1, 2017, 00:00

  • Using Real-World Data (RWD) in Health Technology Assessment (HTA) Practi A Comparative Study of 5 HTA Agencies

    Oct 1, 2017, 00:00

  • Payer Management Of High-Cost Brand-On-Brand Combination Therapies In Oncology

    Oct 1, 2017, 00:00

  • Examination of Effectiveness of Group Physiotherapy Using Dash Questionnaire After Distal Radial Fracture

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Chronic Heart Failure in Slovak Republic

    Oct 1, 2017, 00:00

  • An Economic Evaluation Model for Follicular Lymphoma (FL)- Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational Data

    Oct 1, 2017, 00:00

  • Costs Associated with Disease Progression in Advanced Melanoma - A Claims Analysis Using A Novel Staging Algorithm

    Oct 1, 2017, 00:00

  • Health Care Cost In Patients Undergoing Electrical Cardioversion- An Analysis From The Edoxaban Versus Warfarin In Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Study

    Oct 1, 2017, 00:00

  • Changes in acute medication cost observed in cluster headache patients treated with sphenopalatine ganglion (SPG) stimulation- a U.K. NHS-specific analysis based on data from the pathway R1 registry

    Oct 1, 2017, 00:00

  • Impact Of Health Policies On Catastrophic Health Expenditures In Turkey

    Oct 1, 2017, 00:00

  • Risk Factors And Diagnosis Of Nontuberculous Mycobacterial Lung Disease (NTMLD) In Incident Cohorts Of Bronchiectasis (BE) And Chronic Obstructive Pulmonary Disease (COPD) In A National US Managed Care Insurance Plan

    Oct 1, 2017, 00:00

  • An Assessment Of Correlation Between Mortality And Distance From Patient’s Residence To Interventional Center In Percutaneous Coronary Intervention In Brazil

    Oct 1, 2017, 00:00

  • Barriers To Effective Treatment Of Patients With Cll In Poland In Comparison To The United Kingdom

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Single Fraction Versus Multiple Fraction Radiotherapy in Patients with Painful Bone Metastases; an Iranian Patient's Perspective Study

    Oct 1, 2017, 00:00

  • Cost of Non-Union In Patients with Lower Leg Fractures

    Oct 1, 2017, 00:00

  • European Initiatives To Enhance Biosimilar Adoption

    Oct 1, 2017, 00:00

  • Reported Limitations In Economic Models for Treatments of Schizophrenia- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Costo Utilidad De Los Bloqueadores HER2 Contra El Cáncer De Mama Metastásico En Mujeres Peruanas

    Oct 1, 2017, 00:00

  • Using Diabetes Self-Management Questionnaire (DSMQ) to Assess Diabetes Self-Care Activities for Diabetes Patients in King Fahad University Hospital - Saudi Arabia

    Oct 1, 2017, 00:00

  • Clinical Outcomes of Theophylline use as Add-On Therapy In Patients with Chronic Obstructive Pulmonary Disease- A Propensity Score Matching Analysis

    Oct 1, 2017, 00:00

  • Comparison Of Elderly Care Recipients’ Social Care-Related Quality Of Life (SCRQOL) With Health Related Quality Of Life (HRQOL) In Japan

    Oct 1, 2017, 00:00

  • Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan

    Oct 1, 2017, 00:00

  • Prescribing Pattern Of Antibiotics For Acinetobacter Infection In A Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • The Impact of The Learning Curve on Costs and Effects of Novel Medical Devices. Evidence From Registry Data

    Oct 1, 2017, 00:00

  • Economic Burden of Chronic Respiratory Diseases In Austria

    Oct 1, 2017, 00:00

  • Burden of Genital Warts in Argentina. Preliminary Report of an Observational Study

    Oct 1, 2017, 00:00

  • Economic Impact Of Severe Asthma In Spain- Observational Longitudinal Multicenter Study

    Oct 1, 2017, 00:00

  • Assessing Preferences in Discrete Choice Experiments (DCES)- Effects of the Applied Design on the Study Results

    Oct 1, 2017, 00:00

  • Consumers’ Assessment On Integrated Delivery System In Remote Areas In Taiwan

    Oct 1, 2017, 00:00

  • What is The Economic Impact of CCP Test Misclassification in Rheumatoid Arthritis Diagnosis? A Benchmarking Simulation Study in Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Interventions That Have Not Shown Clinical Effectiveness

    Oct 1, 2017, 00:00

  • Development of Pharmacoeconomic Guidelines In Ukraine- Methodological Issues And Policy Implications

    Oct 1, 2017, 00:00

  • Centralization And Complexity Of Drug Market Access Process Across Italian Regions

    Oct 1, 2017, 00:00

  • Analgesics Prescription Pattern In A Specialist Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Boceprevir and Telaprevir Effectiveness and Safety in A Brazilian Cohort of Chronic Hepatitis C Genotype 1 Patients- A Multicentric Longitudinal Study

    Oct 1, 2017, 00:00

  • Bringing Molecular Diagnostic Tests Into Clinical Practi Mapping The Evidence Pathway

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Pancreatic Adenocarcinoma Patients Treated At The Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Attitude Of Pakistani Pharmacy Students Towards Postgraduate Education

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer in Patients From Argentina

    Oct 1, 2017, 00:00

  • Imagem Corporal EM Mulheres Submetidas Ao Tratamento Do Câncer De Mama

    Oct 1, 2017, 00:00

  • Comparing Inhaled Corticosteroids and Long-Acting Beta Agonists Combination To Inhaled Corticosteroids on Risk of Ischemic Cardiovascular Diseases in Patients with Asthma

    Oct 1, 2017, 00:00

  • Estimating The Lifetime Total Economic Costs Of Respiratory Disease In Beef And Dairy Calves In The UK

    Oct 1, 2017, 00:00

  • Rheumatoid Arthritis Patients’ Perspectives On The Value Of Patient Preferences In Regulatory Decision-Making During Drug Development- A Qualitative Study

    Oct 1, 2017, 00:00

  • Evaluation Of Branding Impact On Iranian Pharmaceutical Market- A Qualitative Study

    Oct 1, 2017, 00:00

  • Quality Assured Use of Pharmaceuticals- Does German Gba Follow Ema?

    Oct 1, 2017, 00:00

  • Economic Analysis of Alk Related Companion Diagnosis Methods Before the Targeted Therapy for Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Classification of Causes of Hospitalization For Heart Failure Patients In Cost-Effectiveness and Cost-Utility Evaluations of Pharmacotherapeutic, Surgical, and Managed-Care Interventions- Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Plurogel® - A New Micelle-Matrix-Based Dressing With 1% Silver Sulphadiazine – In The Management of Non-Healing Wounds

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of A Two-Dose Human Papillomavirus Vaccination Schedule in Colombia

    Oct 1, 2017, 00:00

  • Burden of Healthcare Costs for Merkel Cell Carcinoma Management in Spain

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location - A Time-Trade-Off Study in the Italian General Population

    Oct 1, 2017, 00:00

  • Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Compare the Efficacy and Safety Of Antipsychotics As Maintenance Treatment For Patients With Schizophrenia

    Oct 1, 2017, 00:00

  • Ageing of the Working Population and Disability Insuran An Economic and Demographic Analysis on the Disability Benefit in Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Compared with Standard Treatment in Patients with Acute Ischaemic Stroke

    Oct 1, 2017, 00:00

  • Occurrence Of Skeletal-Related Events (SRE) In Patients With Solid Tumors (ST) And Multiple Myeloma (MM) In Germany- Early Versus Late Initiation of Sre Preventative Agents (SPA)

    Oct 1, 2017, 00:00

  • Access Gap To Innovative Treatments In Romania

    Oct 1, 2017, 00:00

  • Representativeness of Routinely Collected Patient-Reported Outcome Data in Coronary Revascularization Patients?

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Darunavir-Based Regimens For Treatment-Experienced Patients With Multidrug-Resistant HIV-1 Infection In Thailand

    Oct 1, 2017, 00:00

  • Applying The Institute For Clinical And Economic Review’s (ICER) Methodology To Canada- An Improved Way To Take Into Consideration Drug Affordability Challenges?

    Oct 1, 2017, 00:00

  • Characterization of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed with Arterial Hypertension and Diabetes in Colombian Population in the Year 2016

    Oct 1, 2017, 00:00

  • Parental Satisfaction With Medications Therapy And Parenting Stress Among Parents With Asthmatic Children

    Oct 1, 2017, 00:00

  • Assessment of The Efficacy of The Two-Year Treatment With Omalizumab, According to The Pediatric Registry of The Children with Severe Persistent Uncontrolled Asthma

    Oct 1, 2017, 00:00

  • Correlation of Minimal Clinically Important Differences Between Patient Reported Outcome Measures Related To Spinal Surgery

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Evaluate The Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis

    Oct 1, 2017, 00:00

  • Effectiveness of Telemonitoring Interventions for Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Vaccines- What Are The Methodological Issues?

    Oct 1, 2017, 00:00

  • Analyzing Ovarian Cancer Recurrence After Tumor Resection in Other Sites Through The Brazilian Public Healthcare Claim Databases (DATASUS)

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes of Opioid-Induced Constipation as Identified Through Social Media

    Oct 1, 2017, 00:00

  • Retrospective Survey for Hepatitis B Virus Reactivation During Immunosuppressive Therapies For Rheumatoid Arthritis Using Administrative Data

    Oct 1, 2017, 00:00

  • HTA Reports In Gene And Cell Therapy Products- A Scoping Review

    Oct 1, 2017, 00:00

  • Quantifying Standard Of Care (SOC) Hospital-Related Resource Utilisation For Metastatic Uveal Melanoma (MUM) Patients In Nhs England (NHSE) Using The Hospital Episodes Statistics (HES) Dataset

    Oct 1, 2017, 00:00

  • Trend In Hospital Cases of Acquired Hemophilia A (AHA) 2010-2015 In Germany

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)

    Oct 1, 2017, 00:00

  • Length of Hospitalisation After Attune® Knee Joint Arthroplasty (TKA) - Results of A German Retrospective Database Analysis

    Oct 1, 2017, 00:00

  • Method Of Extrapolation- Estimation Of The Impact Of The Proportional Hazard Assumption On The Efficacy Estimation

    Oct 1, 2017, 00:00

  • Valor Monetario De Las Muertes De Motociclistas En Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Flash Glucose Monitoring System Based On Real-World Usage For Type 2 Diabetes (T2DM) Patients Using Intensive Insulin- A Swedish Perspective

    Oct 1, 2017, 00:00

  • Cost Illness Of Rsv Infection In Colombia

    Oct 1, 2017, 00:00

  • Network Meta-Analysis of Treatments For Unresectable Hepatocellular Carcinoma

    Oct 1, 2017, 00:00

  • Health State Utilities In Patients with Relapsing Remitting Multiple Sclerosis Treated with Cladribine Tablets

    Oct 1, 2017, 00:00

  • Multipathogen Detection Methods For l. Monocytogenes In Food Sample- A Systematic Review

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Supra-Ciliary Microstent Device Utilization In Primary open Angle Glaucoma Patients In A Spanish Hospital Outpatient Setting

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Diagnostic Technologies for Dementia- A Systematic Review of Economic Evaluations

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands

    Oct 1, 2017, 00:00

  • Can We Use Demqol-Proxy With Confidence? Robust Solutions To Practical Problems

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Diabetes-Induced Nephropathy- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Assessing the Longer-Term Efficacy of Biologic Therapies and Apremilast for Patients with Moderate-To-Severe Psoriasis- A Systematic Review and Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Analysis Of Financial Status And The Investment Strategy Of National Hospital Organization (NHO) In Japan From 2004 TO 2015

    Oct 1, 2017, 00:00

  • Avaliação Da Qualidade De Vida EM Crianças E Adolescentes COM ASMA

    Oct 1, 2017, 00:00

  • Early HTA Advice In European Countries- Scope And Associated Costs

    Oct 1, 2017, 00:00

  • Mapping From The Womac To The EQ-5D-5L Questionnaire- Comparison Of Different Methodologies

    Oct 1, 2017, 00:00

  • Health Effects of Micronutrient Fortified Milk and Cereal Food for Children and Adolescents- A Systematic Review

    Oct 1, 2017, 00:00

  • Avaliação Dos Custos Por Tipo De Internação Em Uma Operadora De Planos De Saúde- Uma Análise De Dados Do Mundo Real

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy

    Oct 1, 2017, 00:00

  • Patient Characteristics and Disease Burden of Psoriasis In Mexico- A Real-World Physician and Patient Survey

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Influence of Computer Games on the Health and Quality of Students Academic Performance

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Care Perception At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Financial Impact of Introducing Sc Trastuzumab (HERCEPTIN) Versus Currently Used IV Trastuzumab (HERCEPTIN) on The Budgets of Different Hospitals Across Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Mapping from SF-36 Trial Data To EQ-5D Utilities in Advanced Basal Cell Carcinoma

    Oct 1, 2017, 00:00

  • The Impact of The Rads Assessment- Can Fewer Injections With Intravitreal Aflibercept Translate To Lower Overall Treatment Burden and Costs In Wamd When Compared With Intravitreal Ranibizumab?

    Oct 1, 2017, 00:00

  • Characteristics Of Patients Treated With Cetuximab-Based Extreme Regimen In 1ST Line R/M Scchn Cancer In Real Life Setting, In France In 2012-2015

    Oct 1, 2017, 00:00

  • Exploratory Analysis Of The Reasons For Creating Worldwide Translations Of Patient Reported Outcome Instruments

    Oct 1, 2017, 00:00

  • Pathways to Dementia Diagnosis and Post-Diagnostic Support- the Bavarian Dementia Survey

    Oct 1, 2017, 00:00

  • Calidad De Vida En Salud En Pacientes Amputados De Extremidad Inferior Con Protesis De Un Hospital De Especilidad Público Chileno

    Oct 1, 2017, 00:00

  • Comparison Of Women’s Health Care In Germany, Austria And Switzerland Regarding Surgical Therapy Options For Patients With Abnormal Uterine Bleeding

    Oct 1, 2017, 00:00

  • 2017 Update of Recent Trends in Multiple Sclerosis-Related Health Technology Assessment Decisions- An Assessment of Five Countries

    Oct 1, 2017, 00:00

  • Evaluation Of Structured Educational Intervention To Community Pharmacists Towards Adverse Drug Reaction Reporting And Monitoring In South Indian District

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Aspects of Various Strategies of Vessel Sealing and Reduction of Postoperative Complications of Inguinal Lymph Nodes Dissection in Patients with Gynecologic Cancers

    Oct 1, 2017, 00:00

  • Adjusting for Selection Bias in Evaluating Two-Dose Human Papillomavirus Vaccine Coverage Among Adolescents in the United States

    Oct 1, 2017, 00:00

  • Estimation Of The Health-Related Quality Of Life Benefits Of Treatment For Spinal Muscular Atropy (SMA)

    Oct 1, 2017, 00:00

  • Epidemiology Of Healthcare Registered As Sexual Abuse Against Women In Brazil

    Oct 1, 2017, 00:00

  • Value Based Healthcare In Orthopaedic Surgery- An Evaluation Based On The Economist Intelligence Unit Global Assessment Framework

    Oct 1, 2017, 00:00

  • Gamification, What Is It and How Can It Be Used In Health Outcomes Research?

    Oct 1, 2017, 00:00

  • Can The Barthel IndeX (BI) Be Reliably Used Within Economic Evaluation? An Examination Of The Complementarity Of The BI And The Euroqol 5 Dimensions 3 Level (EQ-5D-3L)

    Oct 1, 2017, 00:00

  • Predictive Analysis for Identifying Patient Characteristics Associated with Primary Medication Nonadherence for Lipid Lowering Therapies

    Oct 1, 2017, 00:00

  • Does The Nice Diagnostics Assessment Programme Use An Empirical Icer Threshold?

    Oct 1, 2017, 00:00

  • Does Using Factor Analysis to Select Covariates in Mapping Algorithms Improve Predictive Accuracy? A Case of Mapping the Core 23-Item Women’s Health Questionnaire Onto the EQ-5D-5L and SF-6D

    Oct 1, 2017, 00:00

  • “It’s All Relative” – Exploring The Challenges During Cultural Adaptation Of Family Names In PRO (Patient Reported Outcomes) Questionnaires

    Oct 1, 2017, 00:00

  • The Case For Combination Therapy - Clinical And Economic Value Differentiation Strategies In Saturated Oncology Therapy Areas

    Oct 1, 2017, 00:00

  • Improper Medication Use By The Aged Population In Bahria Town, Lahore, Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Budget Impact of Alectinib in The Treatment of Naïve Anaplastic Lymphoma Kinase-Positive (ALK+) Advanced Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer- An Economic Evaluation Of The PET-PANC Cohort Study

    Oct 1, 2017, 00:00

  • German Situation of Treatment with Biological Agents Among Patients with Psoriasis Based on A Claims Data Analysis

    Oct 1, 2017, 00:00

  • Labour Productivity Losses Associated with Breast Cancer- An Analysis Along A Decade in Spain

    Oct 1, 2017, 00:00

  • Plan De Atencion De Cuidados Paliativos Y Cuidados De Fin De Vida

    Oct 1, 2017, 00:00

  • Quimioterápicos Orais No Tratamento De Segunda Linha Do Carcinoma De Células Renais- Comparação De Custos E Perfil De Reações Adversas

    Oct 1, 2017, 00:00

  • A Review Of Methodology And Response To Iqwig Report “Treatment Of Haemophilia Patients”

    Oct 1, 2017, 00:00

  • Evidence Syntheses On The Economic Value Of Hospital Antimicrobial Stewardship Programs [ASPS] – A Call To Action

    Oct 1, 2017, 00:00

  • Using Ticagrelor to Enhance Outcomes for Acute Coronary Syndromes (ACS) Patients at Low Middle Income Countries

    Oct 1, 2017, 00:00

  • Increased Prevalence of Diabetes In The Netherlands Is Only Partly Explained By Changes In Age And Sex Over Time

    Oct 1, 2017, 00:00

  • Which PSM Method To Use? Association Between Chosen Ppropensity Score Method And Outcomes Of Retrospective Real-World Treatment Comparisions- Evaluation Of 18 Different PSM Methods

    Oct 1, 2017, 00:00

  • Does The Reimbursement Of In-Patient Hospital Services Adequately Cover Novel Antibiotic Pharmaceuticals In The U.S., EU4 And England? Discussion Of Current Mechanisms In Place

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Argentina

    Oct 1, 2017, 00:00

  • Economic Analysis Of The Lutonix® 035 Drug Coated Balloon Pta Catheter For The Treatment Of Vascular Access Stenosis In Patients With Arteriovenous Fistulas

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Interventions For Preventing Chemotherapy Induced Oral Mucositis In Adult Cancer Patients- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • The Practice of Decision-Making of Public Health Authorities In Poland on Reimbursement of Orphan Drugs

    Oct 1, 2017, 00:00

  • Prioritizing Patient-Relevant Attributes of HIV Medications- A Mixed Methods Approach

    Oct 1, 2017, 00:00

  • Drug Cost Containment And Negotiation Power

    Oct 1, 2017, 00:00

  • A Systematic Review Of Predictive Models In Acute Heart Failure

    Oct 1, 2017, 00:00

  • An Algorithm To Quantttatively Estimate Extrapolated Lifetime Survival Curves For Economic Evaluation (EE) of Cancer Treatments When Only Aggregated Patient Data Are Available; With Application To Metastatic Pancreatic Cancer

    Oct 1, 2017, 00:00

  • Use Of The Ims Core Diabetes Model (CDM) In A Long-Term Projected Health Economic Comparison Of CSII And MDI Treatments Of Type 1 Diabetes (T1D) In A Newly-Diagnosed Population Of Paediatric Patients

    Oct 1, 2017, 00:00

  • Revisiting Indirect Health Preference Elicitation As A Base Case

    Oct 1, 2017, 00:00

  • Prevalence of Obstructive Sleep Apnea in German In-Hospital Patients

    Oct 1, 2017, 00:00

  • Preferences for Survival in Non-Small Cell Lung Cancer- Swinging for Home Runs or Base Hits?

    Oct 1, 2017, 00:00

  • Importance Of Tendering After Patent Expiry In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Inpatient Rehabilitation Compared To Home Discharge Following Longer Stay In General Or Neurological Ward, After Admission For The First Ever Stroke In Greece

    Oct 1, 2017, 00:00

  • Overall Survival (OS) Versus Progression-Free Survival (PFS)- Is There A Rational For Replacing One Outcome For The Other?

    Oct 1, 2017, 00:00

  • Healthcare Interventions For Improving Quality Use Of Antibiotics In The Hospital Setting- A Systematic Review

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Patients in Colombia

    Oct 1, 2017, 00:00

  • Clinical Efficacy And Safety Of Licensed Drugs And Potential New Therapies For Non-Metastatic Castration-Resistant Prostate Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Quality of Life Among Patients with Diabetes Mellitus at King Abdulaziz University Hospital in Saudi Arabia

    Oct 1, 2017, 00:00

  • Assessing Health-Related Quality Of Life In Patients With Psoriasis Compared With The Portuguese Population

    Oct 1, 2017, 00:00

  • Too Broad To Be Sensitive? Exploring The Responsiveness Of The Icecap-O Capability Wellbeing Measure Compared To The EQ-5D-3L To The Change Of Clinical And Qol Aspects In People With Parkinson’s

    Oct 1, 2017, 00:00

  • Very Low Compliance for Vulvovaginal Atrophy (VVA) Treatment- A Retrospective U.S. Healthcare Claims Database Analysis

    Oct 1, 2017, 00:00

  • Integrated Care Models In Germany – Potential Market Access Route For Medical Devices?

    Oct 1, 2017, 00:00

  • Exploring Disinvestment Desicions In The NHS Via Health Economics

    Oct 1, 2017, 00:00

  • Impact Of Time To Reimbursement Of Drug Treatments For Non-Small Cell Lung On Patient Outcomes In Europe And Latin America

    Oct 1, 2017, 00:00

  • Confirmatory Versus Explorative Endpoint Analysis- Decision-Making Under Uncertainty on The Basis of Evidence Available From Market Authorization And Early Benefit Assessment In Germany

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 20mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Empagliflozin (Jardiance®) In Type-2 Diabetes Patients With High Cardiovascular Risk In The South African Setting- A Retrospective Claims Database Analysis

    Oct 1, 2017, 00:00

  • Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in Italy

    Oct 1, 2017, 00:00

  • Evaluación De La Costo-Efectividad De La Prueba De Secuenciación Completa Del Gen Cftr Por Técnica Sanger Para Portadores Asintomáticos En Población Colombiana De Primer, Segundo Y Tercer Grado De Consanguinidad Con Historia Familiar De Fib ...

    Oct 1, 2017, 00:00

  • The Impact of Vaccination And Patient Characteristics on Influenza Vaccination Uptake

    Oct 1, 2017, 00:00

  • Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

    Oct 1, 2017, 00:00

  • Cost Per Median Overall Survival Associated with Abiraterone Acetate and Enzalutamide For Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer in Colombia

    Oct 1, 2017, 00:00

  • Comparing Cost-Effectiveness Of A Centralized Versus Decentralized Stroke Care System- Using Patient-Level Data To Estimate Short- And Longterm Effects

    Oct 1, 2017, 00:00

  • Public Perceptions, Attitudes And Willingness To Pay Towards A Medical Device For Detecting Foot Ulceration In People with Diabetes

    Oct 1, 2017, 00:00

  • Do Budget Impact Analyses For Screening Of Cancers Follow International Guidelines? A Systematic Review

    Oct 1, 2017, 00:00

  • Disease Burden During The “Watchful Waiting” Period In Women With Recurrent Ovarian Cancer In Germany

    Oct 1, 2017, 00:00

  • Frecuencia De Partos Por Cesáreas EN Cartagena, Colombia, 2006 - 2015

    Oct 1, 2017, 00:00

  • The Development of Drug Price Index for Each Health Care Sector in Taiwan

    Oct 1, 2017, 00:00

  • Gasto Farmacéutico Ambulatorio Y Hospitalario En Pacientes Con Cáncer De Mama En La Comunidad De Valencia. Análisis De Lo Grupos De Riesgo Clínico 2014-2015

    Oct 1, 2017, 00:00

  • Costos De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • Treatment Patterns and Impact of Not Achieving Skin Clearance for Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Economic Burden of Heart Failure In Asian Countries

    Oct 1, 2017, 00:00

  • Management of Atherogenic Dyslipidemia in the Primary Care Settting in Spain

    Oct 1, 2017, 00:00

  • An Economic Evaluation of A Psychoeducational Suicide Intervention Programme

    Oct 1, 2017, 00:00

  • Management Of Chronic Gout – A Delphi (CONSENSUS) Consultation Of UK-Based Clinical Experts

    Oct 1, 2017, 00:00

  • Cost-Minimization of Somatropin for GH Deficiency and Turner Syndrome Treatment from SUS Perspective

    Oct 1, 2017, 00:00

  • Risk Of Complications With Minimally Invasive Surgery In Liver Resection

    Oct 1, 2017, 00:00

  • How to Maintain Pharmaceutical Access in Crisis- The Iran FDA Experience

    Oct 1, 2017, 00:00

  • Estudio De Costo Efectividad Del Factor De Coagulación Recombinante IX Unido A Proteina Fc Para El Tratamiento De La Hemofilia B En Chile

    Oct 1, 2017, 00:00

  • The Post-Traumatic Stress Disorder And Medication Adherence Encountered At Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Genotype and Liver Fibrosis Distribution Among Hepatitis C Patients in A Single Center in the South of Brasil- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Comparison of Icd-9 to Icd-10 Crosswalks Derived By Physician and Clinical Coder Vs. Automated Methods

    Oct 1, 2017, 00:00

  • Impacto Do Encaminhamento Precoce Para Cuidados Paliativos NA Utilização De Atendimentos De Emergência Por Pacientes Com Câncer Avançado

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil

    Oct 1, 2017, 00:00

  • Emergency Department Use Among Autosomal Dominant Polycystic Kidney Disease Patients In The US

    Oct 1, 2017, 00:00

  • Resource Use and Associated Costs of Managing Docetaxel-Related Neutropenic Sepsis in Patients with Advanced Non-Small Cell Lung Cancer in The UK Nhs- Reveal-Ns

    Oct 1, 2017, 00:00

  • Allowing Respondents To Skip Items During Electronic Collection Of Patient-Reported Outcome (PRO) Data- Does It Matter?

    Oct 1, 2017, 00:00

  • A Budget-Impact Analysis (BIA) Of Immunizing Adults With Copd With The 13-Valent Vaccine (PCV13) Against Community- Acquired Pneumonia And Pneumococcal Disease

    Oct 1, 2017, 00:00

  • Health Economic Evidence on Non-Pharmacological Interventions For Persons With Dementia- A Systematic Review

    Oct 1, 2017, 00:00

  • Evaluation of The "Sophia Asthme" Support Programme for Asthmatic Adult Patients

    Oct 1, 2017, 00:00

  • Classification of Chronic Obstructive Pulmonary Disease (COPD) Severity According to the Global Initiative for Chronic Obstructive Lung Disease (Gold)- Variations in the Defintion of Gold Groups and Their Impact on Stage Assignment

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In Hospitalization Persistent Severe Asthma Patients

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Detecting Arrhythmias With Insertable Cardiac Monitors (ICM) In Turkey

    Oct 1, 2017, 00:00

  • Dose Appropriateness of Antibiotics- Deciphering Infections in Renal Imprirement

    Oct 1, 2017, 00:00

  • Accumulated Treatment Cost of New Therapies in Multiple Myeloma- Comparing the Combination of Daratumumab, Bortezomib and Dexamethasone with Carfilzomib and Dexamethasone For WHO Have Received at Least One Prior Therapy in Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Landiolol, An Ultra-Short-Acting Beta-Blocker, For Prevention of Postoperative Atrial Fibrillation In Germany

    Oct 1, 2017, 00:00

  • LOS COSTOS Y SU INCIDENCIA EN EL USO DE LA POLIFARMACIA EN EL ADULTO MAYOR EN ECUADOR

    Oct 1, 2017, 00:00

  • Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk

    Oct 1, 2017, 00:00

  • International HTA Experience With Targeted Therapy Approvals For Lung Cancer

    Oct 1, 2017, 00:00

  • Decreasing Acef Score In Patients Underwent Myocardial Infarction Affects Patients’ Life Years Gained

    Oct 1, 2017, 00:00

  • High-Cost Oncology Drugs in Brazil and Mexico- Access Differences Between the Public and Private Settings

    Oct 1, 2017, 00:00

  • Ethical Requirements for the Conduct of Drug Utilization Studies in Latin America- A Cross-Sectional Survey

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years of Age – Aging Positive- A Comparison of Medical Charts And Patients Self-Reported Data

    Oct 1, 2017, 00:00

  • Herpes Zoster Related Healthcare Burden And Costs In Both Immunocompromised (IC) And Ic-Free Populations In The United Kingdom

    Oct 1, 2017, 00:00

  • Breast Cancer Diagnosis Process- An Integrative Evaluation of Five Components

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin As Consolidation Treatment After Autologous Stem-Cell Transplantation in Patients With Hodgkin Lymphoma and Increased Risk of Relapse

    Oct 1, 2017, 00:00

  • Survey Of Nurses’ Knowledge About Surgical Wound Care And Its Complications And The Knowledge Of Wound Dressings

    Oct 1, 2017, 00:00

  • Efficacy and Cost-Effectiveness of Second-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

    Oct 1, 2017, 00:00

  • Sun Protection Knowledge And Behaviour Among University Students In Hungary

    Oct 1, 2017, 00:00

  • Appropriate Ankylosing Spondylitis (AS) Treatment is Delayed For Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Value Added Medicines- Adjustements of HTA Decision Frameworks To Capture Their Full Value

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Socioeconomic And Environmental Determinants In Breast Cancer Incidence And Mortality- Scientiometric Review, 2006 - 2016

    Oct 1, 2017, 00:00

  • Deciding On Universal Rotavirus Vaccination In The Netherlands - Again

    Oct 1, 2017, 00:00

  • Comparative Analysis of The Development of The Bulgarian and The Romanian HTA System

    Oct 1, 2017, 00:00

  • Economic Evaluation of 10% Intravenous Immunoglobulin In Treatment of Primary Immunodeficiencies In Adults In The Russian Federation

    Oct 1, 2017, 00:00

  • Patient Outcomes In Wales- The Proms, Prems Effectiveness Programme (PPEP)

    Oct 1, 2017, 00:00

  • The Risks In Translating Smartphone Strings For Medical Study Smartphones Apps Smartwatches

    Oct 1, 2017, 00:00

  • Costs of Chemotherapy-Induced Adverse Events in Head and Neck Cancer in France

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC)- Sensitivity Analyses And Graphical Diagnostics

    Oct 1, 2017, 00:00

  • Healthcare Resource Use (HRU) in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1)- Retrospective Analysis of The Kids’ Inpatient Database (KID)

    Oct 1, 2017, 00:00

  • How Policy-Makers Should Understand Qualitative Evidence Regarding Public Opinion

    Oct 1, 2017, 00:00

  • Severe Depression as a Risk Factor for Osteoporosis- A Real World Data Study Conducted in Italy

    Oct 1, 2017, 00:00

  • Practicalities Of Using Real-World Evidence (RWE) In Comparative Effectiveness Research (CER)- Learnings From Imi-Getreal

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Peritoneal Dialysis Provision for the Treatment of Chronic Kidney Disease from Public Health Perspective in Chile

    Oct 1, 2017, 00:00

  • Use of Biological Based Therapies and Assessment of Health Related Quality of Life Among Thalassaemia Patients

    Oct 1, 2017, 00:00

  • Perceived Service Quality And Patient Satisfaction At Pharmacy Department In Yogyakarta, Indonesia

    Oct 1, 2017, 00:00

  • Sodium-Glucose Co-Transporter-2 (Sglt-2) Inhibitors And The Risk of Fractures of The Upper or Lower Limb In Patients With Type 2 Diabetes- A Nested-Case Control Study

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Oncological Resection and Reconstruction of the Chest Wall

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC) Of Crizotinib With Standard of Care In Progressed Nsclc ALK+ Patients Based On Real-World Evidence (RWE) And Clinical Trial Data In The Czech Republic

    Oct 1, 2017, 00:00

  • Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analys ...

    Oct 1, 2017, 00:00

  • The Humanistic Burden of Microsatellite Instability-High (MSI-H) Colorectal Cancer (CRC) and Metastatic CRC (MCRC) Patients Treated with Subsequent Line Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In The United Kingdom

    Oct 1, 2017, 00:00

  • Cost Per Life Saved Of Adjunctive Igm-Enriched Immunoglobulin Treatment Of Sepsis In Germany

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes Identifying Victims Of Human Trafficking In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • The Unique Characterisitcs Of Adoptive Immunotherapies For Health Economic Evaluations

    Oct 1, 2017, 00:00

  • Persistence And Concentration Of Prescription Drug Expenditure Among Medicare Beneficiaries 2006-2013

    Oct 1, 2017, 00:00

  • No Price Negotiation – The Strategy Of Aok Bavaria Tested – For Inpatient Hemophilia Care

    Oct 1, 2017, 00:00

  • Transparency Matters- Use Of Digital Software Platform In Replicating Systematic Reviews

    Oct 1, 2017, 00:00

  • Spanish Patient’s Perspective and Preferences for Telemedicine Resources in Type 2 Diabetes Management

    Oct 1, 2017, 00:00

  • Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

    Oct 1, 2017, 00:00

  • Comparison Ofsecukinumab Vs Adalimumab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Quick and Comprehensive Assessment of Narrow Band Imaging (NBI) Using in Digestive Tract Examination

    Oct 1, 2017, 00:00

  • Does Community-Based Health Insurance Reduce Child Stunting? Evidence From Rural Uganda

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

    Oct 1, 2017, 00:00

  • Clinical And Economic Value Of Device-Based Detection Of Atrial Fibrillation In Patients With Cryptogenic Stroke

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use of Enstilar® Compared To Dovobet® Gel In The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino (CCU) EN EL Sector De Obras Sociales De Argentina

    Oct 1, 2017, 00:00

  • Evaluating Community Pharmacists’ Response To Adverse Drug Events Among Women With Pcos- A Simulated-Client Study

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Deteccion De Adn De Virus De Papiloma Humano De Alto Riesgo Para Tamizaje De Cancer De Cuello Uterino En Ecuador

    Oct 1, 2017, 00:00

  • A Cost Minimization Analysis of Azelastine/Fluticasone Combination Nasal Spray Versus Azelastine And Fluticasone Nasal Sprays Monotherapy In Moderate To Severe Allergic Rhinitis- An Experience From Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Worldwide Research Productivity on Biosimilars- A Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Boosting Home Dialysis Uptake By Setting Fixed Modality Ceilings- Is It An Evidence-Based Policy Approach?

    Oct 1, 2017, 00:00

  • Real World Data Analysis Of A Patient-Tailored, Post-Discharge Support Program For Patients Undergoing An Ostomy Surgery In Lowering Readmissions And Emergency Room Visits

    Oct 1, 2017, 00:00

  • The Early Bird Catches The Worm- Measuring The Potential Value Of Mesenchymal Stem Cells Therapy For Septic Shock Using The Early Health Economic Evaluation

    Oct 1, 2017, 00:00

  • Patients’ Preferences Related to Treatments for Endometriosis-Related Pain- Results of a Discrete Choice Experiment in the UK

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use Of Daclatasvir + Asunaprevir in The Treatment of Patients with Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Non-Opioid Analgesic Reimbursement In Europe- A Comparative Study

    Oct 1, 2017, 00:00

  • Quantitative Assessment of Ophthalmologist Prescribing Patterns for Severe Vernal Keratoconjunctivitis (VKC) To Inform Payer Decision Making In The Eu

    Oct 1, 2017, 00:00

  • Impacto Económico De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • The Success Of EU Omp Legislation- An Empirical Analysis

    Oct 1, 2017, 00:00

  • Resource use and Health-Care Costs of Chronic Lymphocytic Leukemia in Slovakia

    Oct 1, 2017, 00:00

  • Yellow Fever’s Next Move- The Rising Fear

    Oct 1, 2017, 00:00

  • Aedes Aegypt- Economic Impact of Prevention Versus Palliation of Diseases Caused By The Mosquito

    Oct 1, 2017, 00:00

  • Survival Outcomes Predicted By A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost Effectiveness Analysis- A Comparison With A Traditional Partitioned Survival Model

    Oct 1, 2017, 00:00

  • Pharmaceutical Assistance Public Funding In A Brazilian City And Its Implications For The Universal Access To Essential Medicines

    Oct 1, 2017, 00:00

  • Health Care Resource Utilization Among Patients With Moderate-To-Severe Plaque Psoriasis In Brazil

    Oct 1, 2017, 00:00

  • Fractional Polynomial NMA Models For Survival Analyses- Results From A Simulation Study

    Oct 1, 2017, 00:00

  • Estimating the Comparative Accuracy of Diagnostic Tests- AN Example using Typhoid Fever

    Oct 1, 2017, 00:00

  • Cost Of Hospital Treatment For Severe And Moderate-To-Severe Influenza In Russia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of First-Line Ceritinib in The Treatment of Alk+ Metastatic Non-Small Cell Lung Cancer (NSCLC) in The United States

    Oct 1, 2017, 00:00

  • A Conceptual Model of The Economics of Visualization In Diagnostics and Surgery

    Oct 1, 2017, 00:00

  • Persistence in Hypertension Therapy in Patients with and Without Depression in Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria

    Oct 1, 2017, 00:00

  • Mapping Of Skin And Soft Tissue Infections Worldwide- An Approach From Literature Review

    Oct 1, 2017, 00:00

  • What Underlies The Observed Hospital Volume-Outcome Relationship?

    Oct 1, 2017, 00:00

  • Burden of Arthritic Manifestations on Psoriatic Patients - Sub-Analysis of Pessoa, A Patient Reported Outcomes Study In Portugal

    Oct 1, 2017, 00:00

  • The Impact of Pharmacist-LED Medication Therapy Management on Medication Adherence in Patients with Type 2 Diabetes Mellitus- A Randomized Controlled Study

    Oct 1, 2017, 00:00

  • Generic Reimbursed Market Shares In Greece From 2012-2016. A Study Based On Age Group Preferences

    Oct 1, 2017, 00:00

  • Systematic Review Of Pivotal Studies Of Oncology Drugs Authorized In Italy Since 2013- Correlation Between Studies’ Main Characteristics And Time To Patient

    Oct 1, 2017, 00:00

  • Conditions And Contextual Factors That Influence The Utility And Application Of Patient Preference Studies- A Study Combining Literature And Focus Groups

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Ceesp Efficiency Opinions and Eligibility Criteria for Assessment Since Its Creation

    Oct 1, 2017, 00:00

  • Safety And Efficacy of Osimertinib As A Therapy In Patients With Egfr T790M Positive Non Small Cell Lung Cancer Patients- A Systematic Review

    Oct 1, 2017, 00:00

  • An Analysis Of HTA And Reimbursement Processes In Eunethta Partner Countries- Implications For Implementing HTA Cooperation

    Oct 1, 2017, 00:00

  • The Burden of Genital Warts In Latin America- A Review of the Evidence

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Kidney Transplantation in Czech Republic

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • The First EQ-5D-5L Value Set In Central And Eastern Europe

    Oct 1, 2017, 00:00

  • Burnout Syndrome among Healthcare Professionals working in Gondar University Hospital, Northwest Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden

    Oct 1, 2017, 00:00

  • Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • Estimating The Prevalece of Depression In Patients With Rheumatoid Arthritis In Korea Using National Health Insurance Claims Data

    Oct 1, 2017, 00:00

  • Management And Cost Analysis Of Cancer Patients Treated With G-CSF- A Cohort Study Based On The French National Healthcare Insurance Database (Echantillon Généraliste Des Bénéficiaires)

    Oct 1, 2017, 00:00

  • 3-Steps Stragety for Patients Early Access to an Unauthorized Medication / Device Project Design (Based on 23 Projects Analyses Including EAP, CUP, NPP, IND, ATU)

    Oct 1, 2017, 00:00

  • Managed Entry Agreements (MEA)- Analysis Of The Current Situation In Middle East And North Africa

    Oct 1, 2017, 00:00

  • Healthcare Costs Of Patients With Acute And Chronic Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation In Belgium- A Retrospective Data Collection And Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects

    Oct 1, 2017, 00:00

  • Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX)- Real World Evidence (RWE) From 27 US Insti ...

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- A Cost Of Illness Analysis In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

    Oct 1, 2017, 00:00

  • Cost Analysis of Pre-Dialysis- A Model in the Brazilian context

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68 (current)
  • 69
  • 70
  • »